Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I liked the letter--Thanks, RG!

Hope, you are right.......

At the end, those actions must finally generate revenues for PTSC. Furthermore, the retail shareholders must participate from those activities, too. Others earn money, and we suffer with a share price of 0.2$ although we own one or the most profitable OTC-stock.

Sure, it takes time and we are still facing the PTO-reex. risk, which nobody should forget. Think RG is on the right way, but he is limited by the BOD, the cash and the "past" as he will have many problem to atract PTSC to new bigger investors at the moment.

Best wishes

S402005

Share
New Message
Please login to post a reply